Cart
sales@molnova.com
EZM0414
CAS No. 2411748-50-8
EZM0414( —— )
Catalog No. M28993 CAS No. 2411748-50-8
EZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 654 | In Stock |
|
| 10MG | 929 | In Stock |
|
| 25MG | 1387 | In Stock |
|
| 50MG | 1823 | In Stock |
|
| 100MG | 2465 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEZM0414
-
NoteResearch use only, not for human use.
-
Brief DescriptionEZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.
-
DescriptionEZM0414 is a selective SEDT2 inhibitor that is mostly used to study diffuse large B lymphocytoma and recurrent or refractory multiple myeloma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorHGPR91
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2411748-50-8
-
Formula Weight400.5
-
Molecular FormulaC22H29FN4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 120 mg/mL (299.63 mM)
-
SMILESCC(=O)N1CCN(CC1)[C@H]1CCC[C@H](C1)NC(=O)C1=CC2=C(F)C=CC(C)=C2N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Haffke M, et al. Structural basis of species-selective antagonist binding to the succinate receptor. Nature. 2019 Oct;574(7779):581-585.
molnova catalog
related products
-
JNJ-64619178
JNJ-64619178 is a selective, orally active, and pseudo-irreversible inhibitor of protein arginine methyltransferase 5 (IC50: 0.14 nM).
-
3-pyridine toxoflavi...
3-pyridine toxoflavin is a potent KDM4C inhibitor, IC50=19nM.
-
SAH-EZH2
EZH2/EPP interaction inhibitor (Kd = 320 nM). Suppresses EZH2 expression and H3K27 trimethylation by PCR2 complex. Arrests proliferation and induces monocyte to macrophage differentiation of MLL-AF9 leukemia cell line.
